Charles Shipman

46 papers receiving 1.5k citations

Peers

Charles Shipman
Comparison fields: 5 of 132
  • Virology 199
  • Infectious Diseases 376
  • Epidemiology 678
  • Hepatology 99
  • Oncology 305
Replace Hiroyuki Hayakawa with:
Hiroyuki Hayakawa Japan
Hanzhong Wang China
Elizabeth Hamilton United Kingdom
James Tamura United States
Robert Cozens Switzerland
Nancy J. Phillips United States
Julia Y. Wang United States
Ke Xing China
D. J. Bauer United Kingdom
Charles Shipman relative to Hiroyuki Hayakawa Japan Hiroyuki Hayakawa's profile →
Citations per field
00.5×1.5×1.9×
Hiroyuki Hayakawa · 1×
Citations per year

Countries citing papers authored by Charles Shipman

Since Specialization
Citations

This map shows the geographic impact of Charles Shipman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Shipman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Shipman more than expected).

Fields of papers citing papers by Charles Shipman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Shipman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Shipman. The network helps show where Charles Shipman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Charles Shipman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles Shipman Line = papers co-authored together Charles Shipman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 199811
2 199722
3 19964
4 199511
5 199315
6 199310
7 199211
8 19918
9 199016
10 199094
11 1990483
12 198920
13 198925
14 198846
15 198136
16 197640
17 197212
18 19722
19 19702
20 19663

About Charles Shipman

Charles Shipman is a scholar working on Microbiology, General Dentistry, Epidemiology, Infectious Diseases and Virology, having authored 47 papers that have together received 1.7k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (14 papers), Cytomegalovirus and herpesvirus research (13 papers), Biochemical and Molecular Research (9 papers), Virus-based gene therapy research (7 papers), HIV/AIDS drug development and treatment (5 papers), Fungal Plant Pathogen Control (4 papers), Animal Virus Infections Studies (3 papers) and Protein purification and stability (3 papers). The work is most often cited by research in Virology (199 citations), Infectious Diseases (376 citations), Epidemiology (678 citations), Hepatology (99 citations) and Oncology (305 citations). Charles Shipman has collaborated with scholars based in United States, Japan and Myanmar. Frequent co-authors include Mark N. Prichard, John C. Drach, Sandra H. Smith, Daniel L. Klayman, L E Holland, Edward K. Wagner, Kevin Anderson, Steven R. Turk, Pauline M. Schwartz and Jill C. Pelling. Their work appears in journals such as Antiviral Research, Antimicrobial Agents and Chemotherapy, The Journal of the American Dental Association, Virology and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026